EpiPen Maker to Finally Pay $465 Million for Ripping Off Taxpayers

EpiPens are the very lifebloods of people with severe, life-threatening allergies, and it’s fair to say that those who need them are basically held hostage to whatever their maker, Mylan, charges. Mylan has been raising EpiPen prices for years, while receiving benefits from government reimbursement programs through Medicaid and Medicare. Mylan has now agreed to pay $465 million in penalties for overcharging the government by misclassifying its drug as generic, when it wasn’t....

Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports